238
Views
22
CrossRef citations to date
0
Altmetric
Original Article

A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6‐month study

, , , , , , , & show all
Pages 929-937 | Accepted 28 Mar 2006, Published online: 12 Apr 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Anuradha V Khadilkar & Rubina M Mandlik. (2015) Epidemiology and treatment of osteoporosis in women: an Indian perspective. International Journal of Women's Health 7, pages 841-850.
Read now
Kim Henriksen, Anne-Christine Bay-Jensen, Claus Christiansen & Morten Asser Karsdal. (2010) Oral salmon calcitonin – pharmacology in osteoporosis. Expert Opinion on Biological Therapy 10:11, pages 1617-1629.
Read now
K. Henriksen, K. M. Bohren, A. C. Bay-Jensen & M. A. Karsdal. (2010) Should biochemical markers of bone turnover be considered standard practice for safety pharmacology?. Biomarkers 15:3, pages 195-204.
Read now

Articles from other publishers (19)

Changjun Chen, Mohammed Alqwbani, Jie Zhao, Ruitong Yang, Songgang Wang & Xin Pan. (2021) Effects of Teriparatide versus Salmon Calcitonin Therapy for the Treatment of Osteoporosis in Asia: A Meta-analysis of Randomized Controlled Trials. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:5, pages 932-942.
Crossref
Shakib Akhter, Abdul Rehman Qureshi, Hussein Ali El-Khechen, Anthony Bozzo, Moin Khan, Rakesh Patel, Mohit Bhandari & Ilyas Aleem. (2020) The efficacy of teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain in post-menopausal osteoporotic patients: A systematic review and meta-analysis. Bone Reports 13, pages 100728.
Crossref
Adolfo Díez-Pérez, Fernando Marin, Erik F. Eriksen, David L. Kendler, John H. Krege & Miguel Delgado-Rodríguez. (2019) Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis. Bone 120, pages 1-8.
Crossref
Yan Yang, Xue-Jun Zhang, Xian-Jun Zhu, Lei Zhang, Ming-Jing Bao, Yang Xian, Ji-Chuan Wu, Li-Mei Liu & Peng-Qiu Li. (2015) Comparison between recombinant human parathyroid hormone (1–34) and elcatonin in treatment of primary osteoporosis. Asian Pacific Journal of Tropical Medicine 8:1, pages 79-84.
Crossref
J.F. Chen, K. H. Yang, Z.L. Zhang, H.C. Chang, Y. Chen, H. Sowa & S. Gürbüz. (2014) A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia. Osteoporosis International 26:1, pages 11-28.
Crossref
Erik F. Eriksen, Tony M. Keaveny, Eileen R. Gallagher & John H. Krege. (2014) Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis. Bone 67, pages 246-256.
Crossref
Chih-Ying Liu, Xin Li, Wen-Yih Chen, Li-Chiao Chang, Yi-Fan Chen, Hsin-Lung Chen, Ya-Sen Sun, Hsiu-Yun Lai & E-Wen Huang. (2014) PEGylation Site-Dependent Structural Heterogeneity Study of MonoPEGylated Human Parathyroid Hormone Fragment hPTH(1–34). Langmuir 30:38, pages 11421-11427.
Crossref
T Songpatanasilp, M Mumtaz, H Chhabra, M Yu & S Sorsaburu. (2014) Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population. Singapore Medical Journal 55:09, pages 493-501.
Crossref
Vishal Gupta, MitulAbhaykumar Shah, SagarKirtibhai Shah & JinenMukeshbhai Shah. (2012) Osteoanabolics. Indian Journal of Endocrinology and Metabolism 16:3, pages 349.
Crossref
MarilynLee Cheng & Vishal Gupta. (2012) Teriparatide - Indications beyond osteoporosis. Indian Journal of Endocrinology and Metabolism 16:3, pages 343.
Crossref
K. Henriksen, J. Bollerslev, V. Everts & M. A. Karsdal. (2011) Osteoclast Activity and Subtypes as a Function of Physiology and Pathology—Implications for Future Treatments of Osteoporosis. Endocrine Reviews 32:1, pages 31-63.
Crossref
Charles A. InderjeethKien ChanPaul Glendenning. (2011) Teriparatide: Its Use in the Treatment of Osteoporosis. Clinical Medicine Insights: Therapeutics 3, pages CMT.S2358.
Crossref
Akimitsu Miyauchi, Toshio Matsumoto, Toshitsugu Sugimoto, Mika Tsujimoto, Margaret R. Warner & Toshitaka Nakamura. (2010) Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases. Bone 47:3, pages 493-502.
Crossref
Ronald A. LehmanJrJr, Anton E. Dmitriev, Mario J. Cardoso, Melvin D. Helgeson, Christine L. Christensen, JoLynne W. Raymond, Tobin T. Eckel & K Daniel Riew. (2010) Effect of Teriparatide [rhPTH(1,34)] and Calcitonin on Intertransverse Process Fusion in a Rabbit Model. Spine 35:2, pages 146-152.
Crossref
D. J. Leeming, K. Henriksen, I. Byrjalsen, P. Qvist, S. H. Madsen, P. Garnero & M. A. Karsdal. (2009) Is bone quality associated with collagen age?. Osteoporosis International 20:9, pages 1461-1470.
Crossref
Stephanie K.A. Blick, Sohita Dhillon & Susan J. Keam. (2009) Spotlight on Teriparatide in Osteoporosis†. BioDrugs 23:3, pages 197-199.
Crossref
Akimitsu Miyauchi, Toshio Matsumoto, Hirofumi Shigeta, Mika Tsujimoto, Daniel Thiebaud & Toshitaka Nakamura. (2008) Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study. Journal of Bone and Mineral Metabolism 26:6, pages 624-634.
Crossref
Morten A Karsdal, Kim Henriksen, Michel Arnold & Claus Christiansen. (2008) Calcitonin ??? A Drug of the Past or for the Future?. BioDrugs 22:3, pages 137-144.
Crossref
Stephanie K A Blick, Sohita Dhillon & Susan J Keam. (2008) Teriparatide. Drugs 68:18, pages 2709-2737.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.